Testing made easy with
Smart Codes

Spend more time with your patients and less time ordering tests. Quest Diagnostics Smart Codes use a patient’s age and risk factors to determine which combination of HPV and select STI testing should be performed, along with an image-guided Pap.

Smart Codes are consistent with American College of Obstetricians and Gynecologists (ACOG) recommendations,a and are available in addition to our standard menu of tests.

Cervical cancer screening and average risk for STIs (CT/NG)

CT/NG, Chlamydia trachomatis/Neisseria gonorrhoeae

Cervical cancer screening and high risk for STIs (CT/NG/Trich)

CT/NG, Chlamydia trachomatis/Neisseria gonorrhoeae For all three Smart Codes, if a patient is over the age of 65: Screening should be discontinued if patient has had adequate negative prior screening resultsb and no history of CIN2+. Recommend continuing routine age-based screening for women with a history of CIN2, CIN3, or adenocarcinoma in situ for a total of 20 years after spontaneous regression of appropriate management of CIN2, CIN3, or adenocarcinoma in situ.2-4

a The age-based offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG recommendations do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the recommendations. Non-imaged Pap tests, as well as the additional testing recommended by ACOG, are available at Quest Diagnostics and may be ordered individually. Visit to find our test menu.

b Defined as 3 consecutive negative Paps or 2 consecutive negative co-tests within the past 10 years, with the most recent test occurring within the past 5 years.

  1. Centers for Disease Control and Prevention. Which STD tests should I get? Last reviewed June 30, 2014. Accessed June 7, 2019.
  2. The American College of Obstetricians and Gynecologists. Annual women’s health care: well woman recommendations. Accessed June 4, 2018.
  3. Committee on Practice Bulletins—Gynecology. Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):e111-e130. doi: 10.1097/AOG.0000000000001708
  4. The American College of Obstetricians and Gynecologists. Practice bulletin no. 140: clinical management guidelines for obstetrician-gynecologists: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstet Gynecol. 2013;122(6):1338-1367. doi: 10.1097/01.AOG.0000438960.31355.9e